Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma

BACKGROUND: Targeting human epidermal growth factor receptor 2 (HER2) with trastuzumab in metastatic esophagogastric adenocarcinoma (EGA) improves survival. The impact of HER2 inhibition in combination with chemoradiotherapy (CRT) in early stage EGA is under investigation. This study analyzed the pa...

詳細記述

保存先:
書誌詳細
出版年:J Gastrointest Oncol
主要な著者: Chan, Ellie, Duckworth, Lizette Vila, Alkhasawneh, Ahmad, Toro, Tania Zuluaga, Lu, Xiaomin, Ben-David, Kfir, Hughes, Steven J., Rossidis, Georgios, Zlotecki, Robert, Lightsey, Judith, Daily, Karen C., Dang, Long, Allegra, Carmen J., King, Brent, George, Thomas J.
フォーマット: Artigo
言語:Inglês
出版事項: AME Publishing Company 2016
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4783750/
https://ncbi.nlm.nih.gov/pubmed/27034783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2015.071
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料